Background Inflammatory biomarkers are associated with severity of coronavirus disease
2019 (COVID-19). However, direct comparisons of their utility in COVID-19 versus other …

Objective To delineate the characteristics and clinical significance of plasma inflammatory
cytokines altered in COVID-19. Design Retrospective, single-centre cohort study. Setting …

Objectives Studies reported associations of inflammatory markers with the severity of COVID-
19, but conclusions were inconsistent. We aimed to provide an overview of the association …

Background The association of pro-inflammatory markers such as interleukin-6 (IL-6) and
other biomarkers with severe coronavirus disease 2019 (COVID-19) is of increasing interest …

Background Patients with severe coronavirus disease 2019 (COVID-19) develop acute
respiratory distress and multi-system organ failure and are associated with poor prognosis …

Background Inflammatory markers are often elevated in patients with COVID-19. The
objective of this study is to assess the prognostic capability of these tests in predicting …

Background: The current knowledge about novel coronavirus-2019 (COVID-19) indicates
that the immune system and inflammatory response play a crucial role in the severity and …

Background The COVID-19 pandemic has resulted in a global humanitarian crisis. Despite
ongoing research, transmission risks and many disease characteristics remained unclear …

Aim: The aim of the study is to study the utility of various inflammatory markers in predicting
outcomes of hospitalized patients with coronavirus disease 2019 (COVID-19) pneumonia …

Background Inflammatory responses contribute to tissue damage in COVID-19 and
community-acquired pneumonia (CAP). Although predictive values of different inflammatory …